Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Seoane

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Pharmacology Research & Perspectives|October 4, 2017
Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover studyJutta Beier, Rainard Fuhr, Beatriz Seoane, et al.
BMC Pulmonary Medicine|November 16, 2014
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized studyDave Singh, Helena Pujol, Anna Ribera, et al.
Chemical Society Reviews|February 19, 2015
Metal-organic framework based mixed matrix membranes: a solution for highly efficient CO2 capture?Beatriz Seoane, Joaquin Coronas, Ignacio Gascon, et al.
BMC Pulmonary Medicine|July 22, 2016
Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPDJutta Beier, Helena Pujol, Beatriz Seoane, et al.
BMJ Open Respiratory Research|January 12, 2017
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trialsLorcan McGarvey, Alyn H Morice, Jaclyn A Smith, et al.
The European Respiratory Journal|June 24, 2017
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot studyHelgo Magnussen, Michael Arzt, Stefan Andreas, et al.
Chemical Society Reviews|August 22, 2020
Spectroscopy, microscopy, diffraction and scattering of archetypal MOFs: formation, metal sites in catalysis and thin filmsMiguel Rivera-Torrente, Laurens D B Mandemaker, Matthias Filez, et al.
Inorganic Chemistry|October 23, 2015
Cation Exchange in Dynamic 3D Porous Magnets: Improvement of the Physical PropertiesThais Grancha, Alvaro Acosta, Joan Cano, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2015
Postsynthetic Improvement of the Physical Properties in a Metal-Organic Framework through a Single Crystal to Single Crystal TransmetallationThais Grancha, Jesús Ferrando-Soria, Hong-Cai Zhou, et al.
Respiratory Research|September 10, 2020
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilatorDave Singh, Victor Balaguer, Carol Astbury, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Pharmacology Research & Perspectives|October 4, 2017
Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover studyJutta Beier, Rainard Fuhr, Beatriz Seoane, et al.
BMC Pulmonary Medicine|November 16, 2014
A dose-ranging study of the bronchodilator effects of abediterol (LAS100977), a long-acting β2-adrenergic agonist, in asthma; a Phase II, randomized studyDave Singh, Helena Pujol, Anna Ribera, et al.
Chemical Society Reviews|February 19, 2015
Metal-organic framework based mixed matrix membranes: a solution for highly efficient CO2 capture?Beatriz Seoane, Joaquin Coronas, Ignacio Gascon, et al.
BMC Pulmonary Medicine|July 22, 2016
Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPDJutta Beier, Helena Pujol, Beatriz Seoane, et al.
BMJ Open Respiratory Research|January 12, 2017
Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trialsLorcan McGarvey, Alyn H Morice, Jaclyn A Smith, et al.
The European Respiratory Journal|June 24, 2017
Aclidinium bromide improves symptoms and sleep quality in COPD: a pilot studyHelgo Magnussen, Michael Arzt, Stefan Andreas, et al.
Chemical Society Reviews|August 22, 2020
Spectroscopy, microscopy, diffraction and scattering of archetypal MOFs: formation, metal sites in catalysis and thin filmsMiguel Rivera-Torrente, Laurens D B Mandemaker, Matthias Filez, et al.
Inorganic Chemistry|October 23, 2015
Cation Exchange in Dynamic 3D Porous Magnets: Improvement of the Physical PropertiesThais Grancha, Alvaro Acosta, Joan Cano, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2015
Postsynthetic Improvement of the Physical Properties in a Metal-Organic Framework through a Single Crystal to Single Crystal TransmetallationThais Grancha, Jesús Ferrando-Soria, Hong-Cai Zhou, et al.
Respiratory Research|September 10, 2020
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilatorDave Singh, Victor Balaguer, Carol Astbury, et al.
Pageof 6